A Comprehensive research study conducted by KD Market Insights on "Anti-depressant Drugs Market by Depressive Disorder (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, and Others) and Product (Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Serotonin Antagonist and Reuptake Inhibitors, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023" report offers extensive and highly detailed historical, current and future market trends in the global and regional/market. The Anti-depressant Drugs Market report includes market size, growth drivers, barriers, opportunities, trends and other information which helps to find new opportunities in this market for the growth of the business through new technologies and developments.

Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. It is a very common condition that affects 1 in every 5 Americans. There are many factors including genes, factors such as stress and brain chemistry that could lead to depression. According to WHO almost 350 million people worldwide were affected with depression in 2016. Antidepressants help maintain balance of various hormones and chemicals in the brain, which helps in the treatment of depression. The global anti-depressant drugs market was valued at $13,755 million in 2016, and is estimated to reach $15,983 million by 2023, registering a CAGR of 2.1% from 2017 to 2023.

Request for Sample @ https://www.kdmarketinsights.com/sample/3533

Key Benefits
This report entails a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.

Market estimations are based on comprehensive analysis of the key developments in the industry.
The global market is comprehensively analyzed with respect to type, method, technology, end user, and region.
In-depth analysis based on geography assists in understanding the regional market to assist in strategic business planning.

The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.

Anti-depressant Drugs Market Key Segments:

By Depression Disorder
- Major Depressive Disorder
- Obsessive-Compulsive Disorder
- Generalized Anxiety Disorder
- Panic Disorder
- Others

By Product
- Tricyclic Antidepressants
- Selective Serotonin Reuptake Inhibitors
- Serotonin-norepinephrine reuptake Inhibitors
- Monoamine oxidase inhibitors
- Serotonin antagonist and reuptake inhibitors
- Others

By Region
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Browse Full Report with TOC @ https://www.kdmarketinsights.com/product/anti-depressant-drugs-market-amr

Table of Contents:
 
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE

CHAPTER 3: MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. MARKET SHARE ANALYSIS
3.4. PORTERS FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.1.1. Increase in Prevalence of Depression
3.5.1.2. Rise in Geriatric Population
3.5.1.3. Increase in Awareness
3.5.2. Restrains
3.5.2.1. Non-Pharmacological Therapies Preferred Over Pharmacological Therapies
3.5.2.2. Poor Efficacy and Safety Profiles
3.5.2.3. Patent Expiry of Antidepressants leading to Weak Pipeline
3.5.3. Opportunities
3.5.3.1. Emergence of Novel Multimodal Therapies

CHAPTER 4: ANTI-DEPRESSANT DRUGS MARKET BY DEPRESSIVE DISORDER
4.1. OVERVIEW
4.1.1. Market Size and Forecast
4.2. MAJOR DEPRESSIVE DISORDER
4.2.1. Key Market Trends & Opportunities
4.2.2. Market Size and Forecast
4.2.3. Market Analysis, by Country
4.3. OBSESSIVE-COMPULSIVE DISORDER
4.3.1. Key Market Trends & Opportunities
4.3.2. Market Size and Forecast
4.3.3. Market Analysis, by Country
4.4. GENERALIZED ANXIETY DISORDER
4.4.1. Key Market Trends & Opportunities
4.4.2. Market Size and Forecast
4.4.3. Market Analysis, by Country
4.5. PANIC DISORDER
4.5.1. Key Market Trends & Opportunities
4.5.2. Market Size and Forecast
4.5.3. Market Analysis, by Country
4.6. OTHERS
4.6.1. Key Market Trends & Opportunities
4.6.2. Market Size and Forecast
4.6.3. Market Analysis, by Country

CHAPTER 5: ANTI-DEPRESSANT DRUGS MARKET BY PRODUCT TYPE
5.1. OVERVIEW
5.1.1. Market Size and Forecast
5.2. TRICYCLIC ANTIDEPRESSANTS
5.2.1. Market Size and Forecast
5.2.2. Market Analysis, by Country
5.3. SELECTIVE SEROTONIN REUPTAKE INHIBITORS
5.3.1. Market Size and Forecast
5.3.2. Market Analysis, by Country
5.4. SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS
5.4.1. Market Size and Forecast
5.4.2. Market Analysis, by Country
5.5. MONOAMINE OXIDASE INHIBITOR
Continue…
 
Check for Discount @ https://www.kdmarketinsights.com/discount/3533 
 
About Us:
KD Market Insights offers a comprehensive database of syndicated research studies, customized reports, and consulting services. These reports are created to help in making smart, instant and crucial decisions based on extensive and in-depth quantitative information, supported by extensive analysis and industry insights.
Our dedicated in-house team ensures the reports satisfy the requirement of the client. We aim at providing value service to our clients. Our reports are backed by extensive industry coverage and is made sure to give importance to the specific needs of our clients. The main idea is to enable our clients to make an informed decision, by keeping them and ourselves up to date with the latest trends in the market.

Contact Us:
 
KD Market Insights
150 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
Email: sales@kdmarketinsights.com
Website: www.kdmarketinsights.com